Abilify preludes sexual misconduct

[Guest guest]

doi:10.1016/S0924-9338(10)70672-6 | How to Cite

or Link Using DOI

Copyright © 2010 Elsevier Masson SAS All rights reserved.

Forensic psychiatry

P02-58 - Sexual misconduct

induced by iatrogenic hyperprolactinaemia

References and further reading may be available for this

article. To view references and further reading you must purchase

this article.

A. Nevely1, A. Frei2

and M. Graf3

1 Psychiatrische Dienste Aargau, Aargau,

Switzerland

2 Luzerner Psychiatrie, Lucerne, Switzerland

3 Universitäre Psychiatrische Dienste Basel,

Basel, Switzerland

Available online 7 June 2010.

Background

Drugs which affect the level of dopamine have also an

impact on the level of prolactine and hence influence the

sexual conduct of patients. Hypersexuality is a well known

side effect of the treatment of Parkinson's' disease,

whereas hyposexuality is a side effect of the

drug-treatment of schizophrenia by classical and some

atypical antipsychotics. The novel antipsychotic drug

Aripiprazole, however, has a partial dopaminergic effect,

causes no hyperprolactinaemia and might alter the sexual

conduct of some schizophrenic patients.

Methods

Three case reports of patients with iatrogenic

forensic-psychiatric relevant hypersexuality.

Case 1: Comparatively young Parkinson-Patient with sexual

desinhibition, frequent visits in brothels contracting

debts and sexual harassment towards women after treatment

with Ropinirol.

Case 2: Chronic hebephrenic patient with homoerotic

paedophilia, who only started molesting boys after

changing medication from Olanzapine to Aripiprazole.

Case 3: Chronic-paranoid young schizophrenic patient with

no criminal record who seriously assaulted a foreign woman

short time after changing from Amisulpiride to

Aripiprazole.

Discussion

Hypersexuality as side effect of the treatment of

Parkinson's disease is well known, it might be more

important an issue, if the patient is young.

Hypersexuality as side effect of the treatment with

partial dopaminergic drugs should be considered in the

drug treatment of schizophrenic patients.

European Psychiatry

Volume 25, Supplement 1, 2010, Page 678

18th European Congress of Psychiatry. February 27, March 2,

2010 - Munich, Germany

[Guest guest]

doi:10.1016/S0924-9338(10)70672-6 | How to Cite

or Link Using DOI

Copyright © 2010 Elsevier Masson SAS All rights reserved.

Forensic psychiatry

P02-58 - Sexual misconduct

induced by iatrogenic hyperprolactinaemia

References and further reading may be available for this

article. To view references and further reading you must purchase

this article.

A. Nevely1, A. Frei2

and M. Graf3

1 Psychiatrische Dienste Aargau, Aargau,

Switzerland

2 Luzerner Psychiatrie, Lucerne, Switzerland

3 Universitäre Psychiatrische Dienste Basel,

Basel, Switzerland

Available online 7 June 2010.

Background

Drugs which affect the level of dopamine have also an

impact on the level of prolactine and hence influence the

sexual conduct of patients. Hypersexuality is a well known

side effect of the treatment of Parkinson's' disease,

whereas hyposexuality is a side effect of the

drug-treatment of schizophrenia by classical and some

atypical antipsychotics. The novel antipsychotic drug

Aripiprazole, however, has a partial dopaminergic effect,

causes no hyperprolactinaemia and might alter the sexual

conduct of some schizophrenic patients.

Methods

Three case reports of patients with iatrogenic

forensic-psychiatric relevant hypersexuality.

Case 1: Comparatively young Parkinson-Patient with sexual

desinhibition, frequent visits in brothels contracting

debts and sexual harassment towards women after treatment

with Ropinirol.

Case 2: Chronic hebephrenic patient with homoerotic

paedophilia, who only started molesting boys after

changing medication from Olanzapine to Aripiprazole.

Case 3: Chronic-paranoid young schizophrenic patient with

no criminal record who seriously assaulted a foreign woman

short time after changing from Amisulpiride to

Aripiprazole.

Discussion

Hypersexuality as side effect of the treatment of

Parkinson's disease is well known, it might be more

important an issue, if the patient is young.

Hypersexuality as side effect of the treatment with

partial dopaminergic drugs should be considered in the

drug treatment of schizophrenic patients.

European Psychiatry

Volume 25, Supplement 1, 2010, Page 678

18th European Congress of Psychiatry. February 27, March 2,

2010 - Munich, Germany

[Guest guest]

doi:10.1016/S0924-9338(10)70672-6 | How to Cite

or Link Using DOI

Copyright © 2010 Elsevier Masson SAS All rights reserved.

Forensic psychiatry

P02-58 - Sexual misconduct

induced by iatrogenic hyperprolactinaemia

References and further reading may be available for this

article. To view references and further reading you must purchase

this article.

A. Nevely1, A. Frei2

and M. Graf3

1 Psychiatrische Dienste Aargau, Aargau,

Switzerland

2 Luzerner Psychiatrie, Lucerne, Switzerland

3 Universitäre Psychiatrische Dienste Basel,

Basel, Switzerland

Available online 7 June 2010.

Background

Drugs which affect the level of dopamine have also an

impact on the level of prolactine and hence influence the

sexual conduct of patients. Hypersexuality is a well known

side effect of the treatment of Parkinson's' disease,

whereas hyposexuality is a side effect of the

drug-treatment of schizophrenia by classical and some

atypical antipsychotics. The novel antipsychotic drug

Aripiprazole, however, has a partial dopaminergic effect,

causes no hyperprolactinaemia and might alter the sexual

conduct of some schizophrenic patients.

Methods

Three case reports of patients with iatrogenic

forensic-psychiatric relevant hypersexuality.

Case 1: Comparatively young Parkinson-Patient with sexual

desinhibition, frequent visits in brothels contracting

debts and sexual harassment towards women after treatment

with Ropinirol.

Case 2: Chronic hebephrenic patient with homoerotic

paedophilia, who only started molesting boys after

changing medication from Olanzapine to Aripiprazole.

Case 3: Chronic-paranoid young schizophrenic patient with

no criminal record who seriously assaulted a foreign woman

short time after changing from Amisulpiride to

Aripiprazole.

Discussion

Hypersexuality as side effect of the treatment of

Parkinson's disease is well known, it might be more

important an issue, if the patient is young.

Hypersexuality as side effect of the treatment with

partial dopaminergic drugs should be considered in the

drug treatment of schizophrenic patients.

European Psychiatry

Volume 25, Supplement 1, 2010, Page 678

18th European Congress of Psychiatry. February 27, March 2,

2010 - Munich, Germany

[Guest guest]

doi:10.1016/S0924-9338(10)70672-6 | How to Cite

or Link Using DOI

Copyright © 2010 Elsevier Masson SAS All rights reserved.

Forensic psychiatry

P02-58 - Sexual misconduct

induced by iatrogenic hyperprolactinaemia

References and further reading may be available for this

article. To view references and further reading you must purchase

this article.

A. Nevely1, A. Frei2

and M. Graf3

1 Psychiatrische Dienste Aargau, Aargau,

Switzerland

2 Luzerner Psychiatrie, Lucerne, Switzerland

3 Universitäre Psychiatrische Dienste Basel,

Basel, Switzerland

Available online 7 June 2010.

Background

Drugs which affect the level of dopamine have also an

impact on the level of prolactine and hence influence the

sexual conduct of patients. Hypersexuality is a well known

side effect of the treatment of Parkinson's' disease,

whereas hyposexuality is a side effect of the

drug-treatment of schizophrenia by classical and some

atypical antipsychotics. The novel antipsychotic drug

Aripiprazole, however, has a partial dopaminergic effect,

causes no hyperprolactinaemia and might alter the sexual

conduct of some schizophrenic patients.

Methods

Three case reports of patients with iatrogenic

forensic-psychiatric relevant hypersexuality.

Case 1: Comparatively young Parkinson-Patient with sexual

desinhibition, frequent visits in brothels contracting

debts and sexual harassment towards women after treatment

with Ropinirol.

Case 2: Chronic hebephrenic patient with homoerotic

paedophilia, who only started molesting boys after

changing medication from Olanzapine to Aripiprazole.

Case 3: Chronic-paranoid young schizophrenic patient with

no criminal record who seriously assaulted a foreign woman

short time after changing from Amisulpiride to

Aripiprazole.

Discussion

Hypersexuality as side effect of the treatment of

Parkinson's disease is well known, it might be more

important an issue, if the patient is young.

Hypersexuality as side effect of the treatment with

partial dopaminergic drugs should be considered in the

drug treatment of schizophrenic patients.

European Psychiatry

Volume 25, Supplement 1, 2010, Page 678

18th European Congress of Psychiatry. February 27, March 2,

2010 - Munich, Germany